InsidersTradesSigma
케이엠제약 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 케이엠제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Banks sector, 케이엠제약 has recorded 50 insider filings. Market capitalisation: €7.8bn. The latest transaction was disclosed on 8 July 2026 (Other). Among the most active insiders: 강일모. All data is accessible without an account.
50
Insider Decl.
0
Thresholds
€109,057
32 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,416 of 26,213 companies
12.2
score / 100
Value6
Quality19
FCF yld-29%
Earn yld-57%
EV/EBITDA·
ROE-13%
Gross mgn24%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 July 2026
Declarations50 total
5,994 sharesKRXDART:20260313000300
Ideal exit: 30 Nov 2026 (T+270)
5,000 sharesShareKRXDART:20260303002152
Ideal exit: 23 Nov 2026 (T+270)
5,000 sharesKRXDART:20260303002221
Ideal exit: 21 Nov 2026 (T+270)
ShareKRXDART:20260209000500
Ideal exit: 25 Oct 2026 (T+270)
25 of 50 declarations
About 케이엠제약
케이엠제약 is a company operating in the finance and banking sector, listed on the XKRX market.